Adcock Ingram Holdings | AIP - Operating Profit



Adcock Ingram Holdings reported ZAR487.33M in Operating Profit for its fiscal semester ending in December of 2024.


Operating Profit Change Date
Adcock Ingram Holdings ZAR 487.33M 8.25M Dec/2024
Alaunos Therapeutics USD -755000 395K Dec/2024
Aspen Pharmacare ZAR 4.78B 1.29B Dec/2024
Avita Medical AUD -9957000 5.64M Dec/2024
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Life Healthcare ZAR 1.81B 721M Sep/2024
Moderna USD -907000000 143M Jun/2025
Netcare ZAR 1.67B 177M Sep/2024
Organon & Co USD 326M 225M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Tectonic Therapeutic USD -22330000 8.34M Jun/2025
Viatris USD 185.4M 3.21B Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025